RecruitingPhase 2NCT06544434

Laser Acupuncture for Meniere Disease

Laser Acupuncture for Meniere Disease: A Randomized Controlled Trial


Sponsor

Beijing Tongren Hospital

Enrollment

324 participants

Start Date

May 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Objective: To evaluate the effect of laser acupuncture for the patients Meniere disease. Methods: We enrolled 324 patients at Beijing Tongren Hospital. Patients completed outcome measures at baseline, 3 months, 6 months, and 12 months. Video head impulse test (vHIT), The Caloric Test, Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry (PTA), and visual scale of ear stuffiness to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • Clinical diagnosis of meniere disease.

Exclusion Criteria2

  • Serious mental illness or social problems, and neurological disorders, and systemic diseases, such as malignant tumors, and other serious consumptive diseases.
  • Planning for pregnancy, those in pregnancy, or those who were lactating.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMultiwave Locked System (MLS) laser (Mphi laser, ASA Srl, Vicenza, Italy)

MLS laser is a class IV NIR laser with two synchronized sources (905 nm with 75 W peak power, pulsed mode; 808 nm with power 1 W, continuous mode). Both laser beams were synchronized, the locked waves work with the range 1-2000 Hz.

DRUGBetahistine Mesylate tablet

Betahistine Mesylate tablet (Merislon, Eisai Co., Ltd., China) with the treatment of 6 mg, 3 times a day.


Locations(1)

Beijing TongRen Hospital, Capital Medical University

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06544434


Related Trials